Literature DB >> 15128992

Bronchiolitis obliterans syndrome in lung transplant recipients: can thin-section CT findings predict disease before its clinical appearance?

Eli Konen1, Carlos Gutierrez, Cecilia Chaparro, Conor P Murray, TaeBong Chung, Jane Crossin, Michael A Hutcheon, Narinder S Paul, Gordon L Weisbrod.   

Abstract

PURPOSE: To determine whether there are thin-section computed tomographic (CT) features that predict bronchiolitis obliterans syndrome (BOS) in lung transplant recipients before the clinical appearance and during the early stages of the disease.
MATERIALS AND METHODS: Two hundred ninety-eight thin-section CT scans obtained in 26 lung transplant recipients who did (study group) and 26 lung transplant recipients who did not (control group) develop BOS were reviewed for the presence of mosaic perfusion, bronchiectasis, bronchial wall thickening, and air trapping. BOS was defined by using the recently revised definition of the International Society for Heart and Lung Transplantation. CT scans obtained in the BOS group were divided into three groups: Group A consisted of the last scans obtained before the clinical appearance of BOS; groups B and C consisted of, respectively, the first and last scans obtained after the clinical appearance of BOS. Scans obtained in the control group were acquired during similar posttransplantation periods and matched to scans in each BOS group. Sensitivity, specificity, and positive and negative predictive values were calculated separately for each subgroup. The optimal threshold for each thin-section CT-depicted abnormality was defined by using receiver operating characteristics analysis.
RESULTS: The sensitivities of air trapping for the diagnosis of BOS during the periods in which the scans in groups A, B, and C were obtained were 50%, 44%, and 64%, respectively; specificities were 80%, 100%, and 80% respectively. Sensitivities of mosaic perfusion were 4%, 20%, and 36%, respectively; specificities were 100%, 96%, and 96%, respectively. Sensitivities of bronchiectasis were 25%, 24%, and 32%, respectively; specificities were 80%, 80%, and 96%, respectively. Sensitivities of bronchial wall thickening were 4%, 24%, and 40%, respectively; specificities were 96%, 84%, and 80%, respectively. Air trapping was seen intermittently in nine (43%) of 21 patients with CT scans that depicted this finding at least once.
CONCLUSION: The value of the finding of air trapping before the clinical appearance and during the early stages of BOS is lower than has been previously reported. When using the recently revised criteria for BOS, the role of thin-section CT as a screening test to evaluate patients with lung transplants appears to be limited.

Entities:  

Mesh:

Year:  2004        PMID: 15128992     DOI: 10.1148/radiol.2312030563

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  Quantitative computed tomography assessment of bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Lee Gazourian; Samuel Ash; Emily E K Meserve; Alejandro Diaz; Raul San Jose Estepar; Souheil Y El-Chemaly; Ivan O Rosas; Miguel Divo; Anne L Fuhlbrigge; Phillip C Camp; Vincent T Ho; Ami S Bhatt; Hilary J Goldberg; Lynette M Sholl; George R Washko
Journal:  Clin Transplant       Date:  2017-04-12       Impact factor: 2.863

2.  Bronchiolitis obliterans following lung transplantation: early detection using computed tomographic scanning.

Authors:  P A de Jong; J D Dodd; H O Coxson; C Storness-Bliss; P D Paré; J R Mayo; R D Levy
Journal:  Thorax       Date:  2006-05-02       Impact factor: 9.139

3.  Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors.

Authors:  Ole Henrik Myrdal; Trond Mogens Aaløkken; Phoi Phoi Diep; Ellen Ruud; Lorentz Brinch; Kristian Fosså; Henrik Mangseth; Johny Kongerud; Liv Ingunn Sikkeland; May B Lund
Journal:  Respiration       Date:  2021-12-22       Impact factor: 3.966

4.  [Value of anti-neutrophil cytoplasmic antibody in assessing the severity of bronchiolitis obliterans in children].

Authors:  Xiao-Wen Chen; De-Hui Chen; Shang-Zhi Wu; Na Xie; Wen-Kuan Liu; Yu-Neng Lin; Ya-Wen Zhang; Qing-Si Zeng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

5.  High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Martin L D Gunn; J David Godwin; Jeffrey P Kanne; Mary E Flowers; Jason W Chien
Journal:  J Thorac Imaging       Date:  2008-11       Impact factor: 3.000

6.  Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Authors:  Lee Gazourian; Anna Maria F Coronata; Angela J Rogers; Gerald L Weinhouse; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Vincent T Ho; Rebecca M Baron; George R Washko
Journal:  Respir Med       Date:  2012-11-26       Impact factor: 3.415

Review 7.  Lung Transplantation: CT Assessment of Chronic Lung Allograft Dysfunction (CLAD).

Authors:  Anne-Laure Brun; Marie-Laure Chabi; Clément Picard; François Mellot; Philippe A Grenier
Journal:  Diagnostics (Basel)       Date:  2021-04-30

Review 8.  A review of bronchiolitis obliterans syndrome and therapeutic strategies.

Authors:  Don Hayes
Journal:  J Cardiothorac Surg       Date:  2011-07-18       Impact factor: 1.637

9.  Thin-section computed tomography findings before and after azithromycin treatment of neutrophilic reversible lung allograft dysfunction.

Authors:  Pim A de Jong; Robin Vos; Geert M Verleden; Bart M Vanaudenaerde; Johny A Verschakelen
Journal:  Eur Radiol       Date:  2011-07-27       Impact factor: 5.315

Review 10.  An update on current treatment strategies for managing bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Ashwini Arjuna; Michael T Olson; Rajat Walia; Ross M Bremner; Michael A Smith; Thalachallour Mohanakumar
Journal:  Expert Rev Respir Med       Date:  2020-10-25       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.